COMMUNIQUÉS West-GlobeNewswire

Affimed to Present at the Jefferies Global Healthcare Conference
30/05/2018
Heidelberg, Germany, May 30, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]
Wake Radiology Launches EnvoyAI Platform in First-of-Kind Implementation
30/05/2018
RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence platform provider, EnvoyAI TM ( www.envoyai.com ), recently completed their first successful customer installation at Wake Radiology ( www.wakerad. [...]
Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in adult patients unfit f
30/05/2018
Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in [...]
Herantis Pharma's Manager's Transactions
30/05/2018
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 30 May 2018 at 9:30 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]
Shire plc : Rule 2.9 Announcement
30/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 May 2018 Shire [...]
ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference
30/05/2018
LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
30/05/2018
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory [...]
Navamedic ASA: Q1 2018 results
30/05/2018
Oslo, May 30, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 42.6 million in the first quarter of 2018, down from NOK 78.2 million in the same period in 2017, following the planned discontinuation of the [...]
INNATE PHARMA : Outcome of Annual General Meeting of May 29, 2018
30/05/2018
OUTCOME of ANNUAL GENERAL MEETING OF MAY 29, 2018 Marseille, France, May 30, 2018, 7:00 AM CEST Innate Pharma (Euronext Paris: FR0010331421 - IPH) announces the results of the voting by shareholders at the Annual [...]
INNATE PHARMA : Résultats de l'Assemblée Générale mixte du 29 mai 2018
30/05/2018
RÉSULTATS DE L'ASSEMBLÉE GÉNÉRALE MIXTE DU 29 MAI 2018 Marseille, le 30 mai 2018, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 - IPH) annonce les résultats du vote des actionnaires à l'Assemblée générale [...]
Amicus Therapeutics Launches Galafold® (Migalastat) for Fabry Disease in Japan
30/05/2018
First Oral Precision Medicine for Fabry Patients with an Amenable Mutation Now Available in Japan CRANBURY, N.J. and TOKYO, May 30, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) has initiated the [...]
Intuitive to Begin Direct Operations in India
30/05/2018
Da Vinci® surgical systems manufacturer names general manager SUNNYVALE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc., (Nasdaq: ISRG ) announced today it has begun direct operations in India, [...]
Assure Holdings Corp. Announces Update
30/05/2018
PARKER, Colo., May 29, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
30/05/2018
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
Keryx Pharmaceuticals Announces Upcoming Investor Presentations
30/05/2018
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced two upcoming [...]
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018
29/05/2018
Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed upsized initial public offering and concurrent private placement raising a total of $119.5 million in gross proceeds CAMBRIDGE, Mass [...]
Dova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
29/05/2018
DURHAM, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Jefferies 2018 [...]
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
29/05/2018
HAMILTON, Bermuda, May 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA ) (“Kiniksa”) announced today the closing of its initial public offering of 8,477,777 Class A common shares at a public [...]
Endocyte to Present at Jefferies Healthcare Conference
29/05/2018
WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]

Pages